Efficacy and safety of sildenafil citrate in pulmonary arterial hypertension (PAH): Results of a multinational, randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Rubin, L
Burgess, G
Parpia, T
Badesch, D
机构：
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[2] Pfizer Ltd, PGRD, Sandwich CT13 9NJ, Kent, England
[3] Univ Colorado, Hlth Sci Ctr, Dept Pulm Sci, Denver, CO USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Crit Care Med, Denver, CO USA
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2005年 / 18卷 / 05期
关键词：
exercise tolerance; pulmonary arterial hypertension; sildenafil;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：93A / 93A
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Ying Zhao
    Yuan-Yuan Yang
    Bao-Lin Yang
    Ya-Wei Du
    Da-Wei Ren
    Hong-Mei Zhou
    Jing Wang
    Hui-Min Yang
    Yao-Xian Wang
    Ying-Ying Zhang
    Sheng-Xian Wu
    Trials, 22
  • [42] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Zhao, Ying
    Yang, Yuan-Yuan
    Yang, Bao-Lin
    Du, Ya-Wei
    Ren, Da-Wei
    Zhou, Hong-Mei
    Wang, Jing
    Yang, Hui-Min
    Wang, Yao-Xian
    Zhang, Ying-Ying
    Wu, Sheng-Xian
    TRIALS, 2021, 22 (01)
  • [43] Efficacy and Safety of Cinnarizine in the Prophylaxis of Migraine in Children: A Double-Blind Placebo-Controlled Randomized Trial
    Ashrafi, Mahmoud Reza
    Salehi, Soodeh
    Malamiri, Reza Azizi
    Heidari, Morteza
    Hosseini, Seyed Ahmad
    Samiei, Mahboubeh
    Tavasoli, Ali Reza
    Togha, Mansoureh
    PEDIATRIC NEUROLOGY, 2014, 51 (04) : 503 - 508
  • [44] Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: A randomized, double-blind, placebo-controlled trial
    Plourde, PV
    Reiter, EO
    Jou, HC
    Desrochers, PE
    Rubin, SD
    Bercu, BB
    Diamond, FB
    Backeljauw, PF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09): : 4428 - 4433
  • [45] The Efficacy and Safety of Milnacipran for Treatment of Fibromyalgiae. A Randomized, Double-blind, Placebo-controlled Trial
    Mease, Philip J.
    Clauw, Daniel J.
    Gendreau, R. Michael
    Rao, Srinivas G.
    Kranzler, Jay
    Chen, Wei
    Palmer, Robert H.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) : 398 - 409
  • [46] Efficacy and safety of diacerein monotherapy in adults with obesity: A randomized, double-blind, placebo-controlled trial
    Xiang, Yingying
    Shen, Lixuan
    Xue, Yingying
    Wang, Ziwei
    Zhou, Ruonan
    Cao, Yue
    Zhu, Ziwei
    Xu, Pingyuan
    Yu, Xizhong
    Fang, Penghua
    Shang, Wenbin
    DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 5293 - 5303
  • [47] Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
    Camm, A. John
    Toft, Egon
    Torp-Pedersen, Christian
    Vijayaraman, Pugazhendhi
    Juul-Moller, Steen
    Ip, John
    Beatch, Gregory N.
    Dickinson, Garth
    Wyse, D. George
    EUROPACE, 2012, 14 (06): : 804 - 809
  • [48] Efficacy and safety of corticosteroids in the treatment of CP/CPPS: A randomized, double-blind, placebo-controlled trial
    Dimitrakov, JD
    Tchitalov, J
    Dikov, D
    JOURNAL OF UROLOGY, 2004, 171 (04): : 61 - 62
  • [49] Efficacy and Safety of Vilazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Trial
    Pomara, Nunzio
    Gommoll, Carl
    Chen, Dalei
    Nunez, Rene
    Mathews, Maju
    Croft, Harry A.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S378 - S379
  • [50] Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
    Silberstein, Stephen D.
    Lipton, Richard B.
    Dodick, David W.
    Freitag, Frederick G.
    Ramadan, Nabih
    Mathew, Ninan
    Brandes, Jan L.
    Bigal, Marcelo
    Saper, Joel
    Ascher, Steven
    Jordan, Donna M.
    Greenberg, Steven J.
    Hulihan, Joseph
    HEADACHE, 2007, 47 (02): : 170 - 180
12345